Pre-Market Stock News (October 22, 2007)

Print Email

(AAPL) Apple reports earnings after the close.
(ASTE) Astec $0.51 EPS vs $0.70 est; stock down 7%.
(ATG) AGL Resources lowered guidance.
(BOH) Bank of Hawaii $0.96 EPS vs $0.95 est.
(BSC) Bear Stearns and CITIC in China to form a $1 Billion cross-partnership in new capital markets joint venture.
(CEN) Ceridian $0.31 EPS as expected.
(CHKP) Checkpoint Software $0.41 EPS vs $0.38 est; stock indicated up 2%.
(HAL) Halliburton $0.66 EPS vs $0.64 est.
(HAR) Harman International received an amended $400 million investment from KKR & Goldman Sachs in 1.25% senior convertible notes with a $104 convertible price.
(HAS) $0.78 vs $0.72 est.
(JAKK) JAKKS PAcific $1.45 EPS vs $1.30 est.
(LDK) LDK signed a 3-yr contract to supply multicrystalline solar wafers to Canadian Solar (CSIQ).
(MINI) Mobile Mini sees next quarter $0.34-0.35 vs $0.40 est.
(MRK) Merck $0.75 EPS vs $0.69; R$6.1 B vs $6.03B est; stock indicated up marginally.
(MSFT) Microsoft has begun trimming royalties for rivals and handing over more information to open the source code, according to the EU.
(OSIP) OSI and Roche won Tarceva approval in Japan for lung cancer patients.
(PLUG) Plug Power received its largest fuel cell order from Wal-Mart Stores for use in lift trucks at one of the co’s distribution centers; stock up 5%.
(PTA) Penn Treaty announced a new chairman of the board.
(PVTB) Private Bancorp $0.42 EPS as expected.
(RGS) Regis $0.46 EPS vs $0.47 est.
(SGP) Schering-Plough $0.28 EPS vs $0.30 est.
(SHLD) Sears noted as undervalued in Barron’s; stock indicated up 1%.
(TEVA) Teva Pharmaceuticals announced that Adenoscan patent lawsuits have been settled with King Pharma and Astellas.
(THRX) Theravance received an FDA "Approvable Letter" for Telavancin for the treatment of complicated skin and skin structure infections subject to revised labeling or re-analyses of clinical data or additional clinical data; stock down 5%.
(TPTX) TorreyPines Therapeutics says tezampanel met its primary endpoint in Phase IIb clinical trial in acute migraine headache.
(TXN) Texas Instruments reports earnings after the close.
(WMT)  Wal-Mart announces tender offer for full ownership of Seiyu in Japan.
(ZBRA) Zebra Tech $0.43 EPS vs $0.38 est; stock indicated down 1%.

Jon C. Ogg
October 22, 2007